Prof. Rukshana Shroff, United Kingdom
Cardiovascular disease (CVD) outcome after kidney transplantation

Prof. Julien Hogan, France
Donor-derived cell-free DNA (dd-cfDNA) as a non-invasive biomarker of kidney allograft rejection in pediatric kidney transplantation

Dr. Julia Steinke, United States
Association between donor derived cell free DNA, donor specific antibody, and rejection in pediatric kidney transplant recipients

Dr. Vikas Dharnidharka, United States
Donor-derived cell-free DNA elevations with acute rejection types in a multicenter NAPRTCS registry cohort of children with kidney transplants

Dr. Rishil Patel, United Kingdom
Systematic review on the use of donor-derived cell-free deoxyribonucleic acid (ddcfDNA) for diagnosing rejection in paediatric solid organ transplant recipients

Helen Pizzo, United States
Alemtuzumab induction via intravenous vs. subcutaneous administration in pediatric kidney transplantation

Clarkson Crane, United States
Assessment of DSA by serial titration associates with acute rejection severity in pediatric kidney transplant recipients

Dr. Stella Kilduff, United States
The impact of living donor age and sex on pediatric kidney transplant outcomes